NewsRoom Articles - Page 9 of 154 - PsychedelicNewsWire (PNW)

TuesdayJul 23, 2024 10:00 am

Study Explores How Psilocybin Triggers Brain Plasticity, Therapeutic Effects

New research has determined that psilocybin may impact the brain. Psilocybin is the primary psychoactive compound found in hallucinogenic mushrooms. When ingested, it distorts an individual’s perception of time, among other changes. Researchers have observed that in animals, psilocybin causes neuroplasticity in the hippocampus and cortex. The new study was carried out by investigators at the Washington University School of Medicine in St. Louis. For their study, the researchers used functional MRI scans to observe brain activity in seven healthy individuals prior to, during and after they consumed methylphenidate or psilocybin. During the trial, 40 mg of methylphenidate and 25…

ThursdayJul 18, 2024 10:00 am

Study Shows Older Adults Benefit Psychologically from Psychedelic Retreats

Psychedelics such as DMT, LSD and psilocybin have demonstrated promise in the treatment of affective symptoms of a range of disorders. These drugs work by inducing an altered state of consciousness, which includes intensified perceptions and emotions, which have been associated with therapeutic outcomes. However, older individuals haven’t been included in most psychedelic studies, which leaves the effectiveness and safety of these therapies for this age group in limbo. Now, new research has offered new insights into the impact that psychedelics administered during retreats have on older adults. The research demonstrated that older adults recorded improvements in well-being after attending…

TuesdayJul 16, 2024 10:00 am

New Study Shows Psilocybin Cuts Cluster Headache Frequency in Half

Cluster headaches are headaches characterized by severe pain that often occurs on a side of the head or behind one eye. These headaches may last anywhere between 15 minutes to 3 hours and usually strike suddenly, often recurring more than once a day. The pain experienced by patients is often intense and is sometimes accompanied by other symptoms such as restlessness, nasal congestion and redness in the eye. Preliminary studies and anecdotal reports suggest that psilocybin may provide relief for this headache type. However, until now there wasn’t enough scientific evidence to back these claims. New research has determined that…

ThursdayJul 11, 2024 10:00 am

Studies Find Tripping, Microdosing Psilocybin Mushrooms Is Growing

Recently released reports suggest that hallucinogenic mushrooms may be the most popular psychedelic drug of choice for the public. The reports also determined that most individuals preferred microdosing over a full trip, with one study observing a 1,250% increase in internet search history on microdosing. The study, which also found that psilocybin searches began outpacing LSD in 2019, was conducted by epidemiologist Eric Leas. The study also determined that the increase in curiosity on microdosing correlated with changes in policies related to both psychedelics and marijuana. In his study, Leas observed that the more liberal a state became related to…

TuesdayJul 09, 2024 10:00 am

Study Highlights How Psilocybin Impacts Auditory Cortex, Causing Perception Changes

New research has generated new insights into how psilocybin influences the auditory cortex in mice models. Psilocybin is a natural psychedelic compound that is found in more than 200 species of fungi. The compound is known to induce altered states of consciousness when ingested, including changes in cognition, mood and perception. Various studies have investigated the compound’s effectiveness in treating mental-health disorders, including anxiety and depression. While its therapeutic potential is evident, the exact mechanisms via which this psychedelic alters perception and brain function aren’t well understood. Prior studies have shown that psilocybin alters activity patterns in the brain and…

TuesdayJul 02, 2024 10:00 am

CU Denver Unveils Psychedelic Research Center

The University of Colorado Denver recently launched the CU Denver Center for Psychedelic Research. This center is focused on improving the quality of life of individuals by conducting research on the potential benefits psychedelics may possess in the treatment of various mental, neurological, emotional and other health conditions as well as their possible use in the management of chronic, debilitating illnesses such as cancer. Professor Jim Grigsby, executive director and the center’s chief science officer, revealed that a national study was going on and the center was also planning a number of other studies. Grigsby, who teaches psychology at CU…

ThursdayJun 27, 2024 10:00 am

Older Psychedelics Users Reveal Fascinating Brain Function, Study Says

Scientific interest in psychedelics has increased greatly over the past few years as more and more trials determine that these substances possess the therapeutic potential to treat disorders such as post traumatic stress disorder (PTSD), depression or anxiety. Substances with the most promising results include LSD, psilocybin, MDMA and ketamine. Now, results from a recently conducted survey show that psychedelic drugs such as LSD, MDMA and psilocybin may help protect the brain from some features of aging. The survey was carried out in the United States and involved 3,294 adults, all aged between 42 and 92 years of age. The…

TuesdayJun 25, 2024 10:00 am

Analyzing Possible Industry Implications of FDA Advisory Panel Decision on MDMA

About a week ago, an advisory committee to the U.S. Food and Drug Administration (FDA) rejected evidence supporting the approval of MDMA as an alternative treatment for post-traumatic stress disorder (PTSD). This is a deflating moment for many in psychedelic research who have, for years, conducted trials on the drug in an effort to gain approval for commercial distribution. The application reviewed by the advisory committee was presented by Lykos Therapeutics, which concluded phase 2 and 3 trials investigating the effectiveness of MDMA-assisted therapy in managing post-traumatic stress disorder. In their report, the advisors revealed that they went through the…

ThursdayJun 20, 2024 10:00 am

UC Berkeley Research to Investigate How Psychedelics Alter People’s Views

Psychedelic fungi and plants have been used by various Indigenous communities in their healing and spiritual ceremonies for millennia. In the 1950s and 1960s, western therapists, psychiatrists and researchers began looking into whether these drugs could be used to manage mental-health conditions. However, the approval of the Controlled Substances Act halted this research, up until about a decade ago. Now, researchers at the UC Berkeley Center for the Science of Psychedelics are set to begin a study looking into how psychedelic substances shape how humans perceive things. Previous research has determined that the effects of these drugs on an individual’s…

TuesdayJun 18, 2024 10:00 am

Study Suggests Psychedelics Reduce Fear of Death by Impacting Metaphysical Beliefs

Therapeutic interest in psychedelics has grown as researchers learn more about the potential of these substances to manage the symptoms of different mental-health conditions and improve the well-being of individuals. Now, new research has determined that psychedelic experiences can cause a decrease in death anxiety, possibly by changing a person’s metaphysical beliefs. This discovery creates new approaches for understanding how these substances may help people deal with existential fears. For their study, researchers focused on determining if changes in core beliefs on consciousness and the nature of reality could be a key factor in decreasing death anxiety after psychedelics were…

News and publishing service for psychedelic related companies

Contact us: 512.354.7000